Related Experiment Video
Updated: May 9, 2025

07:44
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.4K
Mesothelial and immune cells interplay in the tumor microenvironment
Rong Sheng1, Yujia Yin1, Xipeng Wang1
1Department of Obstetrics and Gynecology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
Trends in Molecular Medicine
|April 30, 2025
Summary
Mesothelial cells (MCs) in the tumor microenvironment (TME) can create an immunosuppressive state, hindering anti-tumor immunity. Understanding MCs
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Mesothelial cells (MCs) are vital for maintaining serosal integrity and homeostasis through cellular interactions.
- Interactions between MCs and tumor cells are recognized in tumorigenesis and progression within the tumor microenvironment (TME).
- Emerging evidence indicates MCs can promote tumor progression by inducing an immunosuppressive TME.
Purpose of the Study:
- To review the immunoregulatory functions of MCs within the TME of mesothelioma and metastatic carcinomas.
- To explore mechanisms by which MCs induce immunosuppression in cancer.
- To assess the impact of MC-mediated immunosuppression on tumor growth and therapeutic responses.
Main Methods:
- Comprehensive literature review of studies investigating mesothelial cells in cancer immunology.
- Analysis of research on cytokine, chemokine, and exosome secretion by MCs.
- Examination of MC interactions with immune cells and tumor cells in the TME.
Main Results:
- MCs secrete factors that recruit and modulate immunosuppressive cells, contributing to an immunosuppressive TME.
- These secreted factors can directly interact with immune cells, suppressing anti-tumor immune responses.
- The immunosuppressive actions of MCs are implicated in the progression of mesothelioma and metastatic pleural/peritoneal carcinomas.
Conclusions:
- Mesothelial cells play a significant immunoregulatory role in the TME, often promoting immunosuppression.
- Understanding MC-driven immunosuppression is crucial for developing effective cancer therapies for mesothelioma and related carcinomas.
- Targeting MC-mediated immunosuppressive mechanisms may offer novel therapeutic strategies.
Related Concept Videos
The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Mesenchymal Stem Cells
4.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.5K

